Latin American Study of 24-hs Symptoms in Chronic obstructive pulmonary disease (COPD) Patients; LASSYC Study

Trial Identifier:	D2287R00112
Sponsor:	AstraZeneca
NCTID::	NCT02789540
Start Date:	June 2016
Primary Completion Date:	October 2016
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service